CXCR2 antagonist

US11136315B2 · kind B2 · utility

Assignee

• Medshine Discovery Inc. · CN

Inventors

• Bin Chen · Shanghai, CN
• Xiawei WEI · Tianfu, CN
• Xuefeng Sun · Chengdu, CN
• Lei Zhang · Beijing, CN
• Zhaoying Xu · Shanghai, CN
• Wenli Li · Baofeng County, CN
• Peng Zhang · Nanhu, CN
• Feng Gao · Beijing, CN
• Yunfu Luo · Shanghai, CN
• Jian Li · Shanghai, CN
• Shuhui CHEN · Shanghai, CN

Key dates

• Filing date: Jan 11, 2019
• Grant date: Oct 5, 2021
• Expiry date: Jan 11, 2039

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/048
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

A compound as a CXCR2 antagonist and an application thereof in preparing a drug as a CXCR2 antagonist. In particular, the present invention relates to a compound represented by formula (II) or an isomer or pharmaceutically acceptable salt thereof.